Browse > Article

EXPRESSION OF THE GENES OF VASCULAR ENDOTHELIAL GROWTH FACTOR AND VON WILLEBRAND FACTOR IN SALIVARY GLAND TUMORS  

Chung, Ji-Hun (Department of Oral and Maxillofacial Surgery, College of Dentistry, Kangnung National University)
Kim, Ji-Hyuk (Department of Oral and Maxillofacial Surgery, College of Dentistry, Kangnung National University)
Park, Young-Wook (Department of Oral and Maxillofacial Surgery, College of Dentistry, Kangnung National University)
Publication Information
Maxillofacial Plastic and Reconstructive Surgery / v.30, no.1, 2008 , pp. 41-51 More about this Journal
Abstract
Mucoepidermoid carcinoma (MEC) is the most common malignant salivary gland tumor which compromises about 6$\sim$8% of all tumors followed by the adenoid cystic carcinoma (ACC) and adenocarcinoma. Most deaths from salivary carcinomas are caused by recurrent or metastatic lesions that are resistant to conventional therapy. Therefore, knowledge of cellular properties and tumor-host interactions that influence the vascular metastasis is important for the design of more effective therapy of salivary carcinomas. Neoangiogenesis is essential for tumor growth, which is postulated to be fundamentally dependent on the induction of stromal neovascularization. However, how neovascularization takes place in live tissue has not been fully established, especially in recruitment and differentiation of endothelial cells in the salivary gland tumors. Vascular endothelial growth factor (VEGF) is a heparin-binding, dimeric polypeptide growth factor known to exert its mitogenic activity specifically on endothelial cells. VEGF has been shown th be directly involved in angiogenesis, which in essential for the pathogenesis of many solid tumors. von Willebrand factor (vWF) is a large multimeric protein synthesized by megakaryocytes and endothelial cells that enable platelets to adhere to exposed subendothelium and, as well, to respond to changes in the blood flow. Recent studies suggest that increased levels of vWF correlate with progression of disease, metastasis, or survival time and thus may have a prognostic significance. vWF is explained as an acute phase proteins which is increased in cancer or as a result of increased endothelial cell synthesis associated with tumor-induced angiogenesis. Due to adhesive properties of vWF, its increased concentrations may also contribute metastasis of tumor. In this study, we determined the mRNA expression of VEGF and vWF in salivary ACC, MEC and pleomorphic adenoma by in situ hybridization. As a result, stronger expression of VEGF and vWF was seen in salivary ACC and MEC which has more invasive nature than the salivary benign tumor.
Keywords
Salivary gland tumors; Vascular endothelial growth factor; von Willebrand factor; In situ hybridization;
Citations & Related Records
Times Cited By KSCI : 6  (Citation Analysis)
연도 인용수 순위
1 Park YW : Celluar and molecular characterization of adenoid cyctic carcinoma of the salivary glands. J Kor Assoc Of Maxillofac Plast And Reconstr Surg 27(2) : 110, 2005   과학기술학회마을
2 Ishibashi H, Shiratuchi T, Nakagawa K et al : Hypoxiainduced angiogenesis of cultured human salivary gland carcinoma cells enhances vascular endothelial growth factor production and basic fibroblast growth factor release. Oral Oncol 37 : 77, 2001   DOI   ScienceOn
3 Weal S, Hiroko IY, Takashi S : Angiogenesis in mucous retention cyst: a human in vivo-like model of endothelial cell differentiation in mucous substrate. J Oral Pathol Med 34 : 30, 2005   DOI   ScienceOn
4 Lim JJ, Kang SM, Lee MR et al : Expression of vascular endothelial growth factor in salivary gland carcinomas and its relation to p53, Ki-67 and prognosis. J Oral Pathol Med 32 : 552, 2003   DOI   ScienceOn
5 Shavit JA, Motto DG : Coagulation and metastasis - an unexpected role for von Villebrand factor. J Thromb Heamost 4 : 517, 2006   DOI   ScienceOn
6 Lee SK, Kim YS, Song IS et al : Improved technique of digoxigenin labeled RNA in situ hybridization. The Korean Journal of Pathology 35 : 98, 2001
7 Bhat TA, Singh RP : Tumor angiogenesis - a potential target in cancer chemoprevention. Food Chem Toxicol : 1, 2007
8 Beltran D, Faquin WC, Gallagher G et al : Selective immunohistochemical comparison of polymorphous lowgrade adenocarcinoma and adenoid cystic carcinoma. J Oral Maxillofac Surg 64 : 415, 2006   DOI   ScienceOn
9 Blot E, Decaudin D, Veyradier A et al : Cancer-related thrombotic microangiopathy secondary to von vellibrand factor-cleaving protease dificiency. Thrombosis Research 106 : 127, 2002   DOI   ScienceOn
10 Davies DE, Chamberlin SG : Targeting the epidermal growth factor receptor for therapy of carcinomas. Biochemical Pharmacology 51 : 1101, 1996   DOI   ScienceOn
11 Bhattacharyya N : Survival and prognosis for cancer of the submandibular gland. J Oral Maxillofac Surg 62 : 427, 2004   DOI   ScienceOn
12 Peter AB, Tijjani U, Alan WW et al : Expression of type 2 nitric oxide synthase and vascular endothelial growth factor in oral dysplasia. J Oral Maxillofac Surg 60 : 1455, 2002   DOI   ScienceOn
13 Park YW, In YS : Immunohistochemical assays for the expression of angiogenic signaling molecules and microvessel density in adenoid cystic carcinomas of human salivary glands. J Kor Assoc Oral Maxillofac Surg 32(6) : 530, 2006   과학기술학회마을
14 Perez DEC, Pires FR, Lopes MA et al : Adenoid cystic carcinoma and mucoepidermoid carcinoma of the maxillary sinus: report of a 44-year experience of 25 cases from a single institution. J Oral Maxillofac Surg 64 : 1592, 2006   DOI   ScienceOn
15 Yih WY, Kratochvil EJ, Stewart CB : Intraoral minor salivary gland neoplasms: review of 213 cases. J Oral Maxillofac Surg 63 : 805, 2005   DOI   ScienceOn
16 Zavero MR : Structure of von villebrand factor and its function in platelet adhesion and thrombus formation. Best Practice & Research Clinical Heamatology 14(2) : 257, 2001   DOI   ScienceOn
17 In YS, Kim SM, Park YW : Comparative immunohistochemical assays for the expression of angiogenic factors in tumors of human salivary glands. J Kor Acad Maxillofac Plast Reconst Surg 29(1) : 10, 2007   과학기술학회마을
18 Shang ZJ, Li JR, Li ZB : Upregulation of serum and tissue vascular endothelial growth factor correlates with angiogenesis and prognosis of oral squamous cell carcinoma. J Oral Maxillofac Surg 65 : 17, 2007
19 Gao ZN, Wei YQ, Yang PS et al : Combined effects of soluble vascular endothelial growth factor receptor FLT-1 gene therapy and cisplantin chemotherapy in human tongue carcinoma xenografts. Oral Oncology 43 : 477, 2007   DOI   ScienceOn
20 Schmugge M, Rand ML, Freedman J : Platelets and von willebrand factor. Transfusion and Apheresis Science 28 : 269, 2003   DOI   ScienceOn
21 Teo NB, Shoker BS, Jarvis C et al : Angiogenesis and invasive recurrence in ductal carcinoma in situ of the breast. European Journal of Cancer 39 : 38, 2003   DOI   ScienceOn
22 Schmidt M, Lichtner RB : EGF receptor targeting in therapy-resistant human tumors. Drug Resistance Updates 5 : 11, 2002   DOI   ScienceOn
23 Jang JH, Kwon KJ, Park YW : Expressions of vascular metastasis related actors in murine orthotopic tumor models of salivary glands. J Kor Acad axillofac Plast Reconst Surg 29(6) : 499, 2007   과학기술학회마을
24 Alfro JT, Andre DN, Priscila PCA et al : Management of salivary gland adenoid cystic carcinoma: institutional experience of a case series. Sao Paulo Med J 124(1) : 26, 2006   DOI   PUBMED
25 Fan X, Yincheng Z, Feng L et al : Expression of IgSF in salivery adenoid cystic carcinoma and its relationship with invasion and metastasis. J Oral Patho Med 34 : 295, 2005   DOI   ScienceOn
26 Bell BR, Dierks EJ, Homer L et al : Management and outmoce of patients with malignant salivary gland tumors. J Oral Maxillofac Surg 63 : 917, 2005   DOI   ScienceOn
27 Pang R, Poon RPT : Angiogenesis and antiangiogenic therapy in hepatocellular carcinoma. Cancer Letters 242 : 151, 2006   DOI   ScienceOn
28 Park YW : Cellular and molecular characterization of adenoid cystic carcinoma of the salivary glands. J Kor Acad Maxillofac Plast Reconst Surg 27(2) : 110, 2005   과학기술학회마을
29 Morganti M, Carpi A, Amo-Takyi B et al : Von Villebrand's factor mediates the adherence of human tumoral cells to human endothelial cells and ticlopidine interferes with this effect. Biomed & Pharmacother 54 : 431, 2000   DOI   ScienceOn
30 Wong YK, Liu CJ, Kwan PC et al : Microvascular density and vascular endothelial growth factor immunoreactivity as predictors of regional lymph node metastasis from betelassociated oral squamous cell carcinoma. J Oral Maxillofac Surg 61 : 1257, 2003   DOI   ScienceOn
31 Hartenbach EM, Olson TA, Moganraj GD et al : Vascular endothelial growth factor(VEGF) expression and survival in human epithelial ovarian carcinomas. Cancer Letters 121 : 169, 1997   DOI   ScienceOn
32 Raguse JD, Gath HJ, Bier J et al : Docetaxel (taxotere) in recurrent high grade mucoepidermoid carnicoma of the major salivary glands. Oral Oncology EXTRA 40 : 5, 2004   DOI   ScienceOn
33 Sidoni A, Derrico P, Simoncelli C et al : Central mucoepidermoid carcinoma of the mandible: report of a case treated 13 years after first radiographic demonstration. J Oral Maxillofac Surg 54 : 1242, 1996   DOI   ScienceOn
34 Ribatti D, Cruz A, Nico B et al : in situ hybridization and immunogold localization of vascular endothelial growth factor receptor-2 on the pericytes of the chick chorioallantoic membrane. Elsevier Science Ltd 17(5) : 262, 2002   DOI   ScienceOn
35 Fukuzawa M, Sugiura H, Koshinaga T et al : Expression of vascular endothelial growth factor and its receptor Flk-1 in human neuroblastoma using in situ hybridization. Journal of Pediatric Surgery 37(12) : 1747, 2002   DOI   ScienceOn
36 Son CW, Kim KW, Kim CH : Study on Expression of glycosaminoglycan in adenoid cystic carcinoma. J Kor Oral Maxillofac Surg 30 : 271, 2004   과학기술학회마을
37 Baj A, Bertolini F, Ferrari S et al : Central mucoepidermoid carcinoma of the jaw in a teenager: a case report. J Oral Maxillofac Surg 60 : 207, 2002   DOI   ScienceOn
38 Paczuski R, Bialkowska A, Kotschy M et al : Von villebrand factor in plasma of patients with advanced stages of larynx cancer. Thrombosis Research 95 : 197, 1999   DOI   ScienceOn
39 Katherine T, John D, Fotis I et al : Management of adenoid cystic carcinoma of minor salivary glands. J Oral Maxillofac Surg 64 : 1114, 2006   DOI   ScienceOn
40 Morganti M, Mittermayer C, Hanze U et al : Expression of tissue-type plasminogen activator, plasminogen activator inhibitor and von willebrand factor in the supernatant of endothelial cell cultures in response to the seeding of adenocarcinoma cell line HRT-18. Biomed & Pharmacother 50 : 373, 1996   DOI   ScienceOn
41 Yao JC : Molecular targeted therapy for carcinoid and islet-cell carcinoma. Best Practice & Research Clinical Endocrinology & Metabolism 21 : 163, 2007   DOI   ScienceOn
42 Kikaku G : Immunohistochemistry. Gakusai Kikaku Co, 2002, p.297